Biorem Inc (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 75 | 74 | 197 | 49 | 55 |
| Income taxes - deferred | 123 | 121 | 512 | 181 | -39 |
| Accounts receivable | -3,346 | 6,352 | -6,462 | 738 | -1,055 |
| Accounts payable and accrued liabilities | 495 | -2,346 | 2,675 | 582 | -375 |
| Other Working Capital | -2,489 | 3,586 | -3,094 | 1,791 | -3,005 |
| Other Operating Activity | 3,245 | -3,608 | 6,210 | -776 | 1,310 |
| Operating Cash Flow | $-1,898 | $4,178 | $38 | $2,564 | $-3,109 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -363 | 121 | -241 | -364 |
| Investing Cash Flow | $-4 | $-363 | $121 | $-241 | $-364 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | N/A | N/A | 185 |
| Debt Repayment | -170 | -228 | 677 | -963 | -165 |
| Other Financing Activity | 0 | 0 | -775 | -365 | 0 |
| Financing Cash Flow | $-170 | $-228 | $-98 | $-1,328 | $20 |
| Exchange Rate Effect | 73 | 23 | -153 | -198 | 344 |
| Beginning Cash Position | 5,902 | 2,292 | 2,383 | 1,585 | 4,696 |
| End Cash Position | 3,904 | 5,902 | 2,292 | 2,383 | 1,585 |
| Net Cash Flow | $-2,071 | $3,587 | $62 | $995 | $-3,454 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,898 | 4,178 | 38 | 2,564 | -3,109 |
| Capital Expenditure | -4 | -363 | N/A | -241 | -364 |
| Free Cash Flow | -1,901 | 3,815 | 38 | 2,324 | -3,474 |